Dr Hamoun Rozati Consultant Profile
Dr Hamoun Rozati is a Consultant Clinical Oncologist at St Bartholomew’s Hospital and The London Clinic, specialising in the management of primary and secondary brain cancers, benign brain tumours and prostate cancer.
Dr Rozati’s clinical practice focuses on precision radiotherapy—including stereotactic radiosurgery (SRS/SRT) and stereotactic ablative radiotherapy (SABR)—alongside modern, evidence-based systemic therapies (hormone therapy, chemotherapy, targeted agents, and immunotherapy). He holds specialised expertise in treating complex intracranial pathologies, including brain metastases, meningiomas, and vestibular schwannomas, working closely with multidisciplinary neurosurgical and urological teams.
Dr Rozati ranked first nationally in the UK Clinical Oncology recruitment programme and completed his specialist training at premier cancer centres, including The Royal Marsden and University College London Hospitals. He holds postgraduate research degrees from Imperial College London and the Institute of Cancer Research.
An active clinical researcher and educator, Dr Rozati serves as a principal investigator on clinical trials, publishes widely in peer-reviewed oncology journals, and regularly presents at international conferences. At St Bartholomew’s, he leads the Stereotactic Radiosurgery (SRS) service and serves as Head of Clinical Oncology Training.